Protozoan Infections
Welcome,         Profile    Billing    Logout  
 41 Companies   29 Products   29 Products   22 Mechanisms of Action   2 Trials   854 News 


«12345678910111213...1617»
  • ||||||||||  artemether/lumefantrine / Generic mfg., mefloquine / Generic mfg.
    Trial completion, Combination therapy:  In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy (clinicaltrials.gov) -  Mar 10, 2015   
    P4,  N=118, Completed, 
    Recruiting --> Active, not recruiting | N=48 --> 25 Active, not recruiting --> Completed
  • ||||||||||  Enrollment closed:  Bihar Evaluation of Social Franchising and Telemedicine (clinicaltrials.gov) -  Feb 27, 2015   
    P=N/A,  N=106380, Active, not recruiting, 
    Recruiting --> Active, not recruiting Enrolling by invitation --> Active, not recruiting
  • ||||||||||  Trial initiation date, Trial primary completion date:  Determination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy (clinicaltrials.gov) -  Feb 25, 2015   
    P=N/A,  N=55, Not yet recruiting, 
    Enrolling by invitation --> Active, not recruiting Initiation date: Jan 2015 --> Jun 2015 | Trial primary completion date: May 2015 --> Dec 2015
  • ||||||||||  chloroquine phosphate / Generic mfg., primaquine / Generic mfg.
    Trial primary completion date:  Safety and Efficacy of Chloroquine and Primaquine for Vivax Malaria in Bhutan (clinicaltrials.gov) -  Feb 20, 2015   
    P=N/A,  N=50, Recruiting, 
    Initiation date: Jan 2015 --> Jun 2015 | Trial primary completion date: May 2015 --> Dec 2015 Trial primary completion date: Jan 2014 --> May 2015
  • ||||||||||  Biomarker, Trial completion:  MicroRNAs as Biomarkers in Patients With Chagas Disease (clinicaltrials.gov) -  Feb 20, 2015   
    P=N/A,  N=60, Completed, 
    Trial primary completion date: Jan 2014 --> May 2015 Recruiting --> Completed
  • ||||||||||  chloroquine phosphate / Generic mfg., primaquine / Generic mfg.
    Trial completion:  Plasmodium Vivax Efficacy Trial in Cruzeiro do Sul, Acre, Brazil (clinicaltrials.gov) -  Feb 5, 2015   
    P=N/A,  N=117, Completed, 
    Not yet recruiting --> Recruiting | Trial primary completion date: Dec 2014 --> Mar 2015 Not yet recruiting --> Completed
  • ||||||||||  TicoVac (tick-borne encephalitis vaccine, whole Virus inactivated) / Pfizer
    Trial primary completion date:  Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) (clinicaltrials.gov) -  Feb 3, 2015   
    P2,  N=160, Recruiting, 
    Not yet recruiting --> Completed Trial primary completion date: Jan 2020 --> Jan 2030
  • ||||||||||  trimethoprim/sulfamethoxazole / Generic mfg.
    Phase classification, Trial primary completion date:  Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda (clinicaltrials.gov) -  Jan 29, 2015   
    P=N/A,  N=400, Not yet recruiting, 
    Active, not recruiting --> Completed Phase classification: P1 --> P=N/A | Trial primary completion date: May 2015 --> Aug 2015
  • ||||||||||  Euvax B (recombinant hepatitis B vaccine) / LG Chem, Menactra (Meningococcal-groups A, C, Y and W-135 polysaccharide diphtheria toxoid conjugate vaccine) / Sanofi
    Phase classification, Trial primary completion date:  Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine (clinicaltrials.gov) -  Jan 28, 2015   
    P1,  N=350, Active, not recruiting, 
    Active, not recruiting --> Completed | N=160 --> 120 Phase classification: P1/2 --> P1 | Trial primary completion date: Oct 2015 --> Mar 2015
  • ||||||||||  Trial completion, Trial primary completion date:  Malaria Transmission Studies in Mali (clinicaltrials.gov) -  Jan 26, 2015   
    P=N/A,  N=650, Completed, 
    Trial primary completion date: Mar 2019 --> May 2015 Recruiting --> Completed | Trial primary completion date: May 2016 --> Jan 2015
  • ||||||||||  Eurartesim (dihydroartemisinin/piperaquine) / Medicines for Malaria Venture, Leadiant Biosci
    Trial primary completion date:  PRINOGAM: Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers (clinicaltrials.gov) -  Jan 22, 2015   
    P3,  N=1200, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: May 2016 --> Jan 2015 Trial primary completion date: Dec 2014 --> Mar 2015
  • ||||||||||  chloroquine phosphate / Generic mfg.
    Enrollment closed, Trial primary completion date:  Chloroquine for Malaria in Pregnancy (clinicaltrials.gov) -  Jan 17, 2015   
    P3,  N=900, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Jan 2015
  • ||||||||||  Trial completion:  PATH Outgrowers: Stimulating Private Sector Malaria Control (clinicaltrials.gov) -  Jan 15, 2015   
    P=N/A,  N=81597, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Jan 2015 Active, not recruiting --> Completed
  • ||||||||||  chloroquine phosphate / Generic mfg., artemether/lumefantrine / Generic mfg.
    Enrollment open:  P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine (clinicaltrials.gov) -  Jan 13, 2015   
    P3,  N=110, Recruiting, 
    Active, not recruiting --> Completed Not yet recruiting --> Recruiting
  • ||||||||||  DSM265 / Medicines for Malaria Venture
    Trial primary completion date:  DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax (clinicaltrials.gov) -  Jan 12, 2015   
    P2a,  N=60, Not yet recruiting, 
    Not yet recruiting --> Recruiting Trial primary completion date: Sep 2015 --> Apr 2016
  • ||||||||||  Trial primary completion date:  LEISH-F3 + GLA-SE and the LEISH-F3 + MPL-SE Vaccine (clinicaltrials.gov) -  Jan 9, 2015   
    P1,  N=48, Active, not recruiting, 
    Trial primary completion date: Sep 2015 --> Apr 2016 Trial primary completion date: Sep 2014 --> Jan 2015
  • ||||||||||  Mosquirix (RTS,S) / GSK
    Enrollment open, Trial initiation date, Trial primary completion date:  A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S (clinicaltrials.gov) -  Jan 7, 2015   
    P1/2,  N=60, Recruiting, 
    N=52 --> 63 Active, not recruiting --> Recruiting | Initiation date: Aug 2014 --> Jan 2015 | Trial primary completion date: Dec 2015 --> Sep 2015
  • ||||||||||  Trial completion, Viral vector:  Adjuvanting Viral Vectored Malaria Vaccines With Matrix M (clinicaltrials.gov) -  Jan 7, 2015   
    P1,  N=23, Completed, 
    Active, not recruiting --> Recruiting | Initiation date: Aug 2014 --> Jan 2015 | Trial primary completion date: Dec 2015 --> Sep 2015 Active, not recruiting --> Completed
  • ||||||||||  atovaquone/proguanil / Generic mfg., artemether/lumefantrine / Generic mfg.
    Enrollment closed:  Evaluation of the Riamet (clinicaltrials.gov) -  Dec 24, 2014   
    P4,  N=317, Active, not recruiting, 
    Active, not recruiting --> Completed Completed --> Active, not recruiting
  • ||||||||||  gentamicin sulfate / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  WR 279,396 Open Label Treatment Protocol in Tunisia (clinicaltrials.gov) -  Dec 19, 2014   
    P2,  N=50, Terminated, 
    N=300 --> 400 | Trial primary completion date: Jun 2015 --> Dec 2015 N=120 --> 50 | Suspended --> Terminated | Trial primary completion date: Aug 2013 --> Jun 2012; This study was closed prematurely due study team travel restrictions.
  • ||||||||||  Trial primary completion date:  Cepheid Rectal Sample Validation Study (clinicaltrials.gov) -  Dec 17, 2014   
    P=N/A,  N=550, Recruiting, 
    N=120 --> 50 | Suspended --> Terminated | Trial primary completion date: Aug 2013 --> Jun 2012; This study was closed prematurely due study team travel restrictions. Trial primary completion date: Nov 2014 --> Feb 2015